Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Jul 13, 2020
Targets & Mechanisms
Verge puts ALS target through COVID-19 paces, leaning on preclinical partners
...Corp. before its direct molecular target was known, apilimod was acquired by LAM Therapeutics and
renamed
...
Read More
BioCentury
|
Jun 27, 2020
Deals
Why the WuXi NextCode split makes strategic sense for the multinational genomics company
...plans on June 23 that would integrate its U.S., Ireland and Icelandic operations under a
renamed
...
Read More
BioCentury
|
Jun 11, 2020
Deals
Cullinan adds first-in-class asset in hot NK cell checkpoint space
...Cullinan said it assumed control of PDI’s operations, structured the unit as a subsidiary and
renamed
...
Read More
BioCentury
|
Apr 4, 2020
Product Development
COVID-19 roundup: FDA’s expanded access program for convalescent plasma; plus more funding from BARDA, tests from Eurofins, BD-BioGx, and more
...taking place June 8-11 will now occur online instead of in San Diego. The meeting,
renamed
...
Read More
BioCentury
|
Jan 2, 2020
Company News
Jan. 3 Company Quick Takes: Illumina, PacBio call off deal; plus Innovax, Innate, J&J-Pulmatrix, Intrexon, Janssen-Provention
...The restructured company, which will sell off the majority of its non-healthcare businesses and be
renamed
...
Read More
BioCentury
|
Dec 5, 2019
Politics & Policy
H.R. 3 to pass House next week, dead on arrival at Senate
...The House will vote next week on H.R. 3, which has been
renamed
the Elijah E...
Read More
BioCentury
|
Nov 6, 2019
Politics & Policy
FDA takes next step in new drug reorganization, including revamping oncology review
...Division of Non-malignant Hematology (DNH). Antimicrobial products, neuroscience The Office of Antimicrobial Products has been
renamed
...
Read More
BioCentury
|
Oct 19, 2019
Finance
Woodford’s empire crumbles. U.K biotech stays standing
...Investment Management was removed as fund manager with immediate effect. The WEIF will also be
renamed
...
Read More
BioCentury
|
Oct 15, 2019
Financial News
Woodford flagship fund implodes as star fund manager axed
...Investment Management was removed as fund manager with immediate effect. The WEIF will also be
renamed
...
Read More
BioCentury
|
Oct 7, 2019
Company News
Oct. 7 Company Quick Takes: Editas-MaxCyte, Goldfinch-Takeda, Prometheus-Takeda, DBV and Galderma
...pivotal trials begin. Goldfinch plans to submit an IND for the compound, which it has
renamed
...
Read More
Items per page:
10
1 - 10 of 328
BioCentury
|
Jul 13, 2020
Targets & Mechanisms
Verge puts ALS target through COVID-19 paces, leaning on preclinical partners
...Corp. before its direct molecular target was known, apilimod was acquired by LAM Therapeutics and
renamed
...
Read More
BioCentury
|
Jun 27, 2020
Deals
Why the WuXi NextCode split makes strategic sense for the multinational genomics company
...plans on June 23 that would integrate its U.S., Ireland and Icelandic operations under a
renamed
...
Read More
BioCentury
|
Jun 11, 2020
Deals
Cullinan adds first-in-class asset in hot NK cell checkpoint space
...Cullinan said it assumed control of PDI’s operations, structured the unit as a subsidiary and
renamed
...
Read More
BioCentury
|
Apr 4, 2020
Product Development
COVID-19 roundup: FDA’s expanded access program for convalescent plasma; plus more funding from BARDA, tests from Eurofins, BD-BioGx, and more
...taking place June 8-11 will now occur online instead of in San Diego. The meeting,
renamed
...
Read More
BioCentury
|
Jan 2, 2020
Company News
Jan. 3 Company Quick Takes: Illumina, PacBio call off deal; plus Innovax, Innate, J&J-Pulmatrix, Intrexon, Janssen-Provention
...The restructured company, which will sell off the majority of its non-healthcare businesses and be
renamed
...
Read More
BioCentury
|
Dec 5, 2019
Politics & Policy
H.R. 3 to pass House next week, dead on arrival at Senate
...The House will vote next week on H.R. 3, which has been
renamed
the Elijah E...
Read More
BioCentury
|
Nov 6, 2019
Politics & Policy
FDA takes next step in new drug reorganization, including revamping oncology review
...Division of Non-malignant Hematology (DNH). Antimicrobial products, neuroscience The Office of Antimicrobial Products has been
renamed
...
Read More
BioCentury
|
Oct 19, 2019
Finance
Woodford’s empire crumbles. U.K biotech stays standing
...Investment Management was removed as fund manager with immediate effect. The WEIF will also be
renamed
...
Read More
BioCentury
|
Oct 15, 2019
Financial News
Woodford flagship fund implodes as star fund manager axed
...Investment Management was removed as fund manager with immediate effect. The WEIF will also be
renamed
...
Read More
BioCentury
|
Oct 7, 2019
Company News
Oct. 7 Company Quick Takes: Editas-MaxCyte, Goldfinch-Takeda, Prometheus-Takeda, DBV and Galderma
...pivotal trials begin. Goldfinch plans to submit an IND for the compound, which it has
renamed
...
Read More
Items per page:
10
1 - 10 of 328
Previous page
Next page